The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Achilles Therapeutics; AstraZeneca; Boston Biomedical; Bristol-Myers Squibb; Eisai; EUSA Pharma; GlaxoSmithKline; Imugene; Incyte; iOncologi; Ipsen; Kyocera; Merck; MSD; Nekta; Novartis; Pfizer; Pierre Fabre; Roche; Sectra ; Vitaccess
Consulting or Advisory Role - Achilles Therapeutics; AstraZeneca; Boston Biomedical; Bristol-Myers Squibb; Eisai; EUSA Pharma; GlaxoSmithKline; iOncologi; Ipsen; Kyocera; Merck; MSD; Nekta; Novartis; Pfizer; Pierre Fabre; Roche; Sectra ; Vitaccess
Research Funding - Achilles Therapeutics (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Covance (Inst); Immunocore (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Safety of weight-based dosing of nivolumab with or without ipilimumab by body mass index (BMI) stratified by sex across 14 CheckMate clinical trials.
 
Jennifer Leigh McQuade
Honoraria - Merck
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Merck
 
Hans J. Hammers
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - ARMO BioSciences; Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; Corvus Pharmaceuticals; exelixis; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck; Novartis; Pfizer
 
Helena Furberg
No Relationships to Disclose
 
Andreas Engert
Honoraria - Chugai Pharma; Hexal; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Takeda
Research Funding - Affimed Therapeutics (Inst); Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Takeda (Inst)
 
Thierry Andre
Honoraria - AMGEN; Bayer; Bristol-Myers Squibb; Pierre Fabre; Roche/Genentech; Sanofi; SERVIER; Ventana Medical Systems
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Clovis Oncology; Gastrointestinal Cancers Advice; Gastrointestinal Cancers Advice; HalioDX; MSD Oncology; Roche/Genentech; SERVIER; Tesaro
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; MSD Oncology; MSD Oncology; Roche; Roche/Genentech; Ventana Medical Systems
 
George Blumenschein
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Virogin Biotech
Consulting or Advisory Role - Abbvie; Adicet Bio; Amgen; ARIAD; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Maverick Therapeutics; MedImmune; Merck; Novartis; Roche; Virogin Biotech; Xcovery
Research Funding - Adaptimmune; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Exelixis; Genentech; GlaxoSmithKline; Immatics; Immunocare Therapies; Incyte; Kite, a Gilead company; Macrogenics; MedImmune; Merck; Novartis; Roche; Tmunity Therapeutics, Inc.; Torque; Xcovery
 
Nizar M. Tannir
Honoraria - Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Lilly; Nektar; Neoleukin Therapeutics; Novartis; Oncorena; Ono Pharmaceutical; Pfizer; Surface Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Nektar; Neoleukin Therapeutics; Novartis; Oncorena; Ono Pharmaceutical; Pfizer; Surface Oncology
Research Funding - Arrowhead Pharmaceuticals; Bristol-Myers Squibb; Calithera Biosciences; Eisai; Epizyme; Exelixis; Lilly; Mirati Therapeutics; Nektar; Pfizer; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Nektar; Neoleukin Therapeutics; Novartis; Onco Pharmaceuticals; Oncorena; Pfizer; Surface Oncology
 
Ari David Baron
Speakers' Bureau - Abbvie; Amgen; Bristol-Myers Squibb; Eisai; Genentech/Roche; Johnson & Johnson; Lilly; Merck
 
James Larkin
No Relationships to Disclose
 
Anthony B. El-Khoueiry
Honoraria - Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche/Genentech
Consulting or Advisory Role - Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Merck
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Nexus Pharmaceuticals Inc
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Biothera; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Helsinn Therapeutics; Incyte; Inivata; Loxo; Merck; Novartis; Peregrine Pharmaceuticals; Pfizer; Synta; Synta
Research Funding - Bristol-Myers Squibb
 
John-Michael Thomas
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Other Relationship - Bristol-Myers Squibb
 
Delphine Hennicken
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Roberto Zoffoli
Employment - Bristol-Myers Squibb
 
Daniel Reshef
Stock and Other Ownership Interests - Bristol-Myers Squibb; Bristol-Myers Squibb (I); Teva; Teva (I)
 
Mary Coffey
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Incyte; Lilly; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); Novartis (Inst); Pfizer (Inst)